Morinda Citrifolia (Noni) Reduces Cancer Risk in Current Smokers by Decreasing Aromatic DNA Adducts

College of Medicine at Rockford, University of Illinois Chicago, Rockford, Illinois 61107, USA.
Nutrition and Cancer (Impact Factor: 2.47). 09/2009; 61(5):634-9. DOI: 10.1080/01635580902825605
Source: PubMed

ABSTRACT Quantitative determination of aromatic DNA adducts in peripheral blood lymphocytes (PBLs) of current smokers is an useful surrogate biomarker for the evaluation of environmental carcinogen exposure or chemopreventive intervention. In this study, we examined the impact of Tahitian Noni Juice (TNJ) on the aromatic DNA adducts of PBLs, before and after a 1-mo intervention, using (32)P postlabeling assay. Of 283 enrolled, 203 smokers completed the trial. Aromatic DNA adducts levels in all participants were significantly reduced by 44.9% (P < 0.001) after drinking 1 to 4 oz of TNJ for 1 mo. Dose-dependent analyses of aromatic DNA adduct levels showed reductions of 49.7% (P < 0.001) in the 1-oz TNJ group and 37.6% (P < 0.001) in the 4-oz TNJ group. Gender-specific analyses resulted in no significant differences in the 4-oz TNJ groups. Interestingly, the 1-oz TNJ group showed a reduction of 43.1% (P < 0.001) in females compared with 56.1% (P < 0.001) in males. The results suggest that drinking 1 to 4 oz of TNJ daily may reduce the cancer risk in heavy cigarette smokers by blocking carcinogen-DNA binding or excising DNA adducts from genomic DNA.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Food plants provide important phytochemicals which help improve or maintain health through various biological activities, including antioxidant effects. Cigarette smoke-induced oxidative stress leads to the formation of lipid hydroperoxides (LOOHs) and their decomposition product malondialdehyde (MDA), both of which cause oxidative damage to DNA. Two hundred forty-five heavy cigarette smokers completed a randomized, double-blind, placebo-controlled clinical trial designed to investigate the effect of noni juice on LOOH- and MDA-DNA adducts in peripheral blood lymphocytes (PBLs). Volunteers drank noni juice or a fruit juice placebo every day for 1 month. DNA adducts were measured by (32)P postlabeling analysis. Drinking 29.5-118 mL of noni juice significantly reduced adducts by 44.6-57.4%. The placebo, which was devoid of iridoid glycosides, did not significantly influence LOOH- and MDA-DNA adduct levels in current smokers. Noni juice was able to mitigate oxidative damage of DNA in current heavy smokers, an activity associated with the presence of iridoids.
    Food Science & Nutrition 03/2013; 1(2):141-9. DOI:10.1002/fsn3.21
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: N-Methyl-N-Nitrosourea (NMU) is a highly specific mammary gland carcinogen, directly acting and does not require metabolic activation. The novel medicinal plant Morinda citrifolia, also called as Noni, has broad therapeutic effects such as antibacterial, antiviral, antifungal, anticancer, analgesic, anti-inflammatory, anti-oxidant and immune enhancing effects. The present study was conducted to assess the beneficial effects of M. citrifolia fruit juice on antioxidant, hematological and biochemical alterations caused by NMU induced mammary carcinogenesis in Sprague-Dawley rats. The rats were divided into five groups viz., vehicle control group-A (n=8), M. citrifolia control group-B (n=8), NMU control group C (n=15), M. citrifolia prevention group-D (n=15) and M. citrifolia treatment group-E (n=15). By the end of the 28 weeks experimental period all the animals were euthanized, blood was collected by heart puncture. M. citrifolia treatment significantly (p < 0.05) increased the anti-oxidant enzymes such as catalase, superoxide dismutase and significantly (p < 0.05) decreased the lipid peroxidation activity when compared to NMU control group-C. M. citrifolia exhibited a preventive effect against anaemia, lymphocytosis and neutrophilia in group-D and group-E when compared to group-C. Biochemical analyses showed normal levels of enzymes of liver and kidney in M. citrifolia treated groups- B, D and E rats, whereas NMU control group-C showed significant (p < 0.05) decrease in albumin and total protein levels. These findings indicate that M. citrifolia fruit juice did not show any hepatotoxic or nephrotoxic effects. It was concluded that the M. citrifolia fruit juice ameliorates the adverse effects of NMU carcinogenesis and could be useful to treat mammary tumours in humans and animals.
    International Journal of Pharmacology 06/2014; 10(2):109-119. DOI:10.3923/ijp.2014.109.119 · 0.98 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Durante este estudio se buscó determinar la frecuencia de uso de medicina alternativa y complementaria (CAM) basada en plantas, en pacientes con cáncer de seno. Se realizó por medio de encuestas en pacientes con cáncer de seno que asistieron a consulta externa al Centro Javeriano de Oncología del Hospital San Ignacio en Bogotá en los meses de Junio a Diciembre del 2011. De las 404 encuestas aplicadas en mujeres con cáncer de seno, el 57% consumieron algún tipo de CAM para el cáncer de seno y de estos el 76% consumieron plantas medicinales como el anamú, la sábila, los frutos rojos y la guanábana, entre otros. El 65% de los pacientes tuvieron una percepción positiva frente al consumo de las plantas medicinales y el 57% de los usuarios de terapias basada en plantas, la uso simultáneamente al tratamiento alopático recomendado por el médico oncólogo. Concluimos que la frecuencia de uso de CAM en pacientes con cáncer de seno del Centro Javeriano de Oncología en Bogotá, esta dentro del rango de prevalencia reportado mundialmente, aunque existen diferencias marcadas en los tipos y frecuencias de CAM consumidas. La alta proporción de pacientes que usan CAM basada en plantas sin discutirlo con el médico oncólogo, tiene como consecuencia la falta de evaluación con respecto a los efectos sinérgicos o antagónicos de estas terapias frente al tratamiento alopático del cáncer de mama; así como el potencial antitumoral y inmunomodulador real de las plantas usadas de manera tradicional por lo pacientes oncológicos.
    Universitas Scientiarum 12/2012; 17(3):291-302.

Full-text (3 Sources)

Available from
May 26, 2014